Flutamide versus prednisone in patients with prostate cancer symptomatically progressing after androgen-ablative therapy: a phase III study of the European organization for research and treatment of cancer genitourinary group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples